ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

Magazines

Cover_EBM_1_2023
Issue Spring 2023

Synthetic Biology: Green new world

Nearly thirty years ago, Bill Gates commented that “DNA is like a com- puter program, but far more advanced than any software ever created.” That recognition, however, was only the first step on … more ➔

Page 2 of 212

LATEST NEWS

Structure of the CD47 proteinPleiotrope - https://commons.wikimedia.org/w/index.php?curid=15999847

Electra Therapeutics raises US$183m in Series C fin...

Ipsen HQIpsen SA

Ipsen acquires ImCheck in US$1bn deal

For the first time taking place in Berlin: ESMO 2025BIOCOM Interrelations

Tubulis presents first clinical data on ADC TUB-040

ADVERTISEMENT

MAGAZINE

1 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

2 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

3 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

4 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

SPONSORED PUBLICATION

1 / 3
Image 960x540
Gene Therapy

Innovative Approaches to Gene Therapy

Watch this expert-led session to explore the latest trends and insights in gene therapy, including how to model immunosuppressive regimens, key study-design considerations, and the importance of age … more ➔

2 / 3
25Q3_Digitizing-Mfg-for-Annex-11-and-MHRA-Rediness_Banners_960x540
Whitepaper Digital Manufacturing

Tackling 5 Key Challenges in Annex 11 and MHRA Readiness

Download the guide to explore how forward-thinking organisations are leveraging digital transformation in manufacturing to overcome regulatory challenges, enhance compliance, and gain operational … more ➔

3 / 3
Monarch_Advertorial_202502_EU
New England Biolabs

The Bridge to your success

Customized Enzymes and Reagents from New England Biolabs. Creating the right partnership is essential when pioneering a new life science product. more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top